Evidence map›Paper›PMID 22942424›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection.

Rodolfo D Vicetti Miguel, Robert L Hendricks, Alfredo J Aguirre, Melissa A Melan, Stephen A K Harvey, Tracy Terry-Allison, Anthony J St Leger, Angus W Thomson, Thomas L Cherpes

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01750476 terminatednot on this map

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

TypeobservationalSponsorThomas Cherpes, DVM, MDRan2012 to 2013Enrolled7ConditionsInitiation of Oral Contraception (OC), Initiation of Depo-Provera (DMPA), Initiation of Mirena (LNG-IUD)ArmsMirena, Oral contraception, Depo-Provera
NCT02011711 completednot on this mapstarted 2013, after this paper: background citation

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

TypeobservationalSponsorThomas L. CherpesRan2013 to 2016Enrolled90ConditionsContraception
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. IL-4-secreting eosinophils promote endometrial stromal cell proliferation and preventProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rodolfo D Vicetti MiguelDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Robert L Hendricks
Alfredo J Aguirre
Melissa A Melan
Stephen A K Harvey
Tracy Terry-Allison
Anthony J St Leger
Angus W Thomson
Thomas L Cherpes
University of Pittsburgh · US

Funding

Modulation of Hormonal and Systemic Immunity by Hormonal Contraceptive UseR01HD072663 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TROUT, WAYNE C · 2012 to 2016
$2.1M
Tregs:sculpting a balance between protection and pathology during viral infectionR56AI085110 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHERPES, THOMAS L. · 2010 to 2010
$374k
NIAID NIH HHS R56 AI085110NIAID NIH HHS R56AI085110NICHD NIH HHS R01 HD072663NICHD NIH HHS R01HD072663
6 · The paper itself

Abstract

Epidemiological studies indicate that the exogenous sex steroid medroxyprogesterone acetate (MPA) can impair cell-mediated immunity, but mechanisms responsible for this observation are not well defined. In this study, MPA administered to mice 1 wk prior to HSV type 1 (HSV-1) infection of their corneal mucosa impaired initial expansion of viral-specific effector and memory precursor T cells and reduced the number of viral-specific memory T cells found in latently infected mice. MPA treatment also dampened expression of the costimulatory molecules CD40, CD70, and CD80 by dendritic cells (DC) in lymph nodes draining acute infection, whereas coculture of such DC with T cells from uninfected mice dramatically impaired ex vivo T cell proliferation compared with the use of DC from mice that did not receive MPA prior to HSV-1 infection. In addition, T cell expansion was comparable to that seen in untreated controls if MPA-treated mice were administered recombinant soluble CD154 (CD40L) concomitant with their mucosal infection. In contrast, the immunomodulatory effects of MPA were infection site dependent, because MPA-treated mice exhibited normal expansion of virus-specific T cells when infection was systemic rather than mucosal. Taken together, our results reveal that the administration of MPA prior to viral infection of mucosal tissue impairs DC activation, virus-specific T cell expansion, and development of virus-specific immunological memory.

Indexed as

Immunologic MemoryAnimalsCell DifferentiationCells, CulturedCoculture TechniquesDendritic CellsFemaleHerpesvirus 1, HumanImmunity, CellularKeratitis, HerpeticMedroxyprogesterone AcetateMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMucous MembraneMedroxyprogesterone Acetate

Identifiers

PMID22942424
PMCPMC3448807
OpenAlexW2134515410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.